Daniel P. O’Day

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

GILD

Current role

CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,795,192	—	$15,238,402	$4,500,060	$4,848,120	$2,055,424	$28,437,198
2024	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,771,201	—	$12,426,816	$4,125,011	$4,028,096	$1,338,268	$23,689,392
2023	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,740,962	—	$11,865,090	$3,749,966	$4,036,200	$1,215,472	$22,607,690
2022	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,691,154	—	$10,603,901	$3,750,014	$4,716,480	$859,704	$21,621,253
2021	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,650,000	—	$9,764,060	$3,375,004	$3,446,190	$994,212	$19,229,466
2020	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,702,885	—	$8,388,056	$3,125,041	$4,713,390	$1,068,723	$18,998,095
2019	Gilead Sciences, Inc. (GILD)	Chairman and Chief Executive Officer	$1,267,692	$5,675,000	$15,500,541	$3,000,002	$3,120,000	$544,619	$29,107,854

No earnings-call appearances or filed executive changes recorded yet.